Analysen zu Reckitt Benckiser Plc
| 19.01.24 | Reckitt Benckiser Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.01.24 | Reckitt Benckiser Buy | UBS AG | |
| 10.01.24 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
| 28.12.23 | Reckitt Benckiser Outperform | Bernstein Research | |
| 20.12.23 | Reckitt Benckiser Neutral | Goldman Sachs Group Inc. | |
| 19.12.23 | Reckitt Benckiser Overweight | Barclays Capital | |
| 18.12.23 | Reckitt Benckiser Underperform | Jefferies & Company Inc. | |
| 18.12.23 | Reckitt Benckiser Buy | UBS AG | |
| 18.12.23 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
| 12.12.23 | Reckitt Benckiser Outperform | RBC Capital Markets | |
| 11.12.23 | Reckitt Benckiser Outperform | Bernstein Research | |
| 10.12.23 | Reckitt Benckiser Underperform | Jefferies & Company Inc. | |
| 29.11.23 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
| 28.11.23 | Reckitt Benckiser Equal Weight | Barclays Capital | |
| 24.11.23 | Reckitt Benckiser Hold | Deutsche Bank AG | |
| 14.11.23 | Reckitt Benckiser Equal-weight | Morgan Stanley | |
| 03.11.23 | Reckitt Benckiser Outperform | RBC Capital Markets | |
| 02.11.23 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
| 27.10.23 | Reckitt Benckiser Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.10.23 | Reckitt Benckiser Hold | Deutsche Bank AG | |
| 26.10.23 | Reckitt Benckiser Buy | UBS AG | |
| 25.10.23 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
| 25.10.23 | Reckitt Benckiser Market-Perform | Bernstein Research | |
| 25.10.23 | Reckitt Benckiser Buy | UBS AG | |
| 25.10.23 | Reckitt Benckiser Outperform | RBC Capital Markets | |
| 25.10.23 | Reckitt Benckiser Hold | Jefferies & Company Inc. | |
| 05.10.23 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
| 02.10.23 | Reckitt Benckiser Hold | Deutsche Bank AG | |
| 25.09.23 | Reckitt Benckiser Outperform | RBC Capital Markets | |
| 13.09.23 | Reckitt Benckiser Overweight | Barclays Capital | |
| 06.09.23 | Reckitt Benckiser Market-Perform | Bernstein Research | |
| 01.09.23 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
| 23.08.23 | Reckitt Benckiser Market-Perform | Bernstein Research | |
| 23.08.23 | Reckitt Benckiser Overweight | Barclays Capital | |
| 23.08.23 | Reckitt Benckiser Hold | Jefferies & Company Inc. | |
| 23.08.23 | Reckitt Benckiser Outperform | RBC Capital Markets | |
| 21.08.23 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
| 14.08.23 | Reckitt Benckiser Market-Perform | Bernstein Research | |
| 08.08.23 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
| 08.08.23 | Reckitt Benckiser Buy | UBS AG | |
| 31.07.23 | Reckitt Benckiser Hold | Jefferies & Company Inc. | |
| 27.07.23 | Reckitt Benckiser Overweight | Barclays Capital | |
| 27.07.23 | Reckitt Benckiser Buy | UBS AG | |
| 27.07.23 | Reckitt Benckiser Hold | Deutsche Bank AG | |
| 27.07.23 | Reckitt Benckiser Neutral | Credit Suisse Group | |
| 27.07.23 | Reckitt Benckiser Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 26.07.23 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
| 26.07.23 | Reckitt Benckiser Buy | UBS AG | |
| 26.07.23 | Reckitt Benckiser Outperform | RBC Capital Markets | |
| 26.07.23 | Reckitt Benckiser Hold | Jefferies & Company Inc. |
Aktuelle Aktienanalysen
| 30.01.25 | T-Mobile US Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | Continental Buy | UBS AG | |
| 30.01.25 | AstraZeneca Neutral | UBS AG | |
| 30.01.25 | Hapag-Lloyd Underweight | JP Morgan Chase & Co. | |
| 30.01.25 | Nokia Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
| 30.01.25 | Roche Underweight | JP Morgan Chase & Co. | |
| 30.01.25 | DWS Group Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | Assicurazioni Generali Buy | Goldman Sachs Group Inc. | |
| 30.01.25 | DWS Group Neutral | UBS AG | |
| 30.01.25 | ABB Neutral | UBS AG | |
| 30.01.25 | Roche Neutral | UBS AG | |
| 30.01.25 | Nokia Neutral | UBS AG | |
| 30.01.25 | Sanofi Buy | UBS AG | |
| 30.01.25 | Nordea Bank Abp Registered Shs Buy | Goldman Sachs Group Inc. | |
| 30.01.25 | Roche Sell | Goldman Sachs Group Inc. | |
| 30.01.25 | Tesla Neutral | Goldman Sachs Group Inc. | |
| 30.01.25 | Hennes & Mauritz AB Buy | UBS AG | |
| 30.01.25 | IBM Buy | Goldman Sachs Group Inc. | |
| 30.01.25 | Meta Platforms Buy | Goldman Sachs Group Inc. | |
| 30.01.25 | Tesla Sell | UBS AG | |
| 30.01.25 | Hennes & Mauritz AB Sell | Goldman Sachs Group Inc. | |
| 30.01.25 | Nokia Sell | Goldman Sachs Group Inc. | |
| 30.01.25 | DWS Group Neutral | Goldman Sachs Group Inc. | |
| 30.01.25 | Henkel vz. Hold | Jefferies & Company Inc. | |
| 30.01.25 | Sartorius vz. Hold | Jefferies & Company Inc. | |
| 30.01.25 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 30.01.25 | Shell Outperform | RBC Capital Markets | |
| 30.01.25 | ASML NV Buy | Goldman Sachs Group Inc. | |
| 30.01.25 | ASML NV Neutral | UBS AG | |
| 30.01.25 | STMicroelectronics Buy | UBS AG | |
| 30.01.25 | STMicroelectronics Neutral | Goldman Sachs Group Inc. | |
| 30.01.25 | ABB Neutral | Goldman Sachs Group Inc. | |
| 30.01.25 | Shell Buy | UBS AG | |
| 30.01.25 | Shell Buy | Goldman Sachs Group Inc. | |
| 30.01.25 | Symrise Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | Symrise Neutral | Goldman Sachs Group Inc. | |
| 30.01.25 | Symrise Add | Baader Bank | |
| 30.01.25 | Symrise Buy | UBS AG | |
| 30.01.25 | Symrise Equal Weight | Barclays Capital | |
| 30.01.25 | ABB Sector Perform | RBC Capital Markets | |
| 30.01.25 | Sartorius Stedim Biotech Buy | Jefferies & Company Inc. | |
| 30.01.25 | BBVA Outperform | RBC Capital Markets | |
| 30.01.25 | Deutsche Bank Buy | UBS AG | |
| 30.01.25 | Henkel vz. Buy | Warburg Research | |
| 30.01.25 | Deutsche Bank Buy | Goldman Sachs Group Inc. | |
| 30.01.25 | Deutsche Bank Overweight | Barclays Capital | |
| 30.01.25 | DWS Group Hold | Jefferies & Company Inc. | |
| 30.01.25 | Deutsche Bank Overweight | JP Morgan Chase & Co. | |
| 30.01.25 | AGRANA neutral | Erste Group Bank |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.